HYUNDAI BIOLAND Co.,Ltd Stock

Equities

A052260

KR7052260007

Personal Products

End-of-day quote Korea S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
8,940 KRW +1.94% Intraday chart for HYUNDAI BIOLAND Co.,Ltd +2.76% -10.42%
Sales 2022 99.15B 72.18M Sales 2023 102B 74.03M Capitalization 150B 109M
Net income 2022 4.76B 3.47M Net income 2023 8.06B 5.86M EV / Sales 2022 2.16 x
Net Debt 2022 12.48B 9.08M Net Debt 2023 9.94B 7.24M EV / Sales 2023 1.57 x
P/E ratio 2022
42.3 x
P/E ratio 2023
18.6 x
Employees 320
Yield 2022
0.52%
Yield 2023
-
Free-Float 65%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.94%
1 week+2.76%
Current month+0.68%
1 month+0.45%
3 months-5.60%
6 months-8.02%
Current year-10.42%
More quotes
1 week
8 430.00
Extreme 8430
8 940.00
1 month
8 430.00
Extreme 8430
11 350.00
Current year
8 430.00
Extreme 8430
11 350.00
1 year
8 430.00
Extreme 8430
13 740.00
3 years
8 430.00
Extreme 8430
24 450.00
5 years
8 430.00
Extreme 8430
48 850.00
10 years
8 430.00
Extreme 8430
48 850.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 20-08-27
Members of the board TitleAgeSince
Chief Executive Officer 56 20-08-27
Director/Board Member 50 -
Director/Board Member 54 20-08-27
More insiders
Date Price Change Volume
24-04-19 8,940 +1.94% 48,592
24-04-18 8,770 +2.57% 58,399
24-04-17 8,550 +1.42% 25,958
24-04-16 8,430 -2.54% 38,350
24-04-15 8,650 -0.92% 26,613

End-of-day quote Korea S.E., April 18, 2024

More quotes
Hyundai Bioland Co Ltd, formerly SK Bio Land Co Ltd, is a Korea-based company mainly engaged in the development and manufacture of raw materials for cosmetics. The Company operates its business through four segments. The Cosmetic Raw Material segment produces products such as portulaca extracts, ulmus extracts, crinum extracts, hyaluronic acids and arbutins. The Pharmaceutical Ingredient segment manufactures and sells products such as phellodendron extracts, ampelopsis extracts and gardenia extracts and others. The Ingredients for Health Functional Food segment produces and distributes red ginseng extract powders, seaweed powders, glucosamine powders, black garlic extract powders, dandelion extract powders, green tea extracts and others. The Medical Device segment involves in the provision of medical equipment such as tissue engineering products, comprised of biological wound dressings and collagen, as well as diagnostic kits, comprised of rapid kits, serological kits and mask packs.
More about the company
  1. Stock Market
  2. Equities
  3. A052260 Stock